A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Participants with Severe Renal Impairment, End-stage Kidney Disease, and in Healthy Participants

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513848-28-00

Acronym

D9440C00003

Enrollment

Registered

2024-10-28

Start date

2024-11-11

Completion date

2025-04-23

Last updated

2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers, Renal Impairment and End Stage Kidney Disease

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Romania

None listed

Source: EU CTIS · Data processed: Feb 4, 2026